Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
Read More…
Industry, Sector and Symbol
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Phone31-20-420-3191
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$700.85 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date10/23/2019 (Confirmed)
OptionableOptionable
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories declared a quarterly dividend on Tuesday, October 8th. Stockholders of record on Friday, October 18th will be given a dividend of $0.55 per share on Tuesday, November 19th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 5.45%. The ex-dividend date of this dividend is Thursday, October 17th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) issued its earnings results on Wednesday, July, 24th. The oil and gas company reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The oil and gas company earned $169.04 million during the quarter, compared to analyst estimates of $173.46 million. Core Laboratories had a return on equity of 51.19% and a net margin of 14.30%. The company's revenue for the quarter was down 3.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.59 EPS. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
How can I listen to Core Laboratories' earnings call?
Core Laboratories will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories updated its third quarter earnings guidance on Wednesday, July, 24th. The company provided EPS guidance of $0.48-0.52 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.50. The company issued revenue guidance of $171-175 million, compared to the consensus revenue estimate of $179.03 million.
What price target have analysts set for CLB?
13 brokerages have issued 12 month price objectives for Core Laboratories' stock. Their forecasts range from $44.00 to $120.00. On average, they anticipate Core Laboratories' share price to reach $72.18 in the next year. This suggests a possible upside of 78.7% from the stock's current price. View Analyst Price Targets for Core Laboratories.
What is the consensus analysts' recommendation for Core Laboratories?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.
Has Core Laboratories been receiving favorable news coverage?
News stories about CLB stock have been trending negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Core Laboratories earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned news stories about the oil and gas company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Core Laboratories.
Are investors shorting Core Laboratories?
Core Laboratories saw a increase in short interest in September. As of September 30th, there was short interest totalling 3,340,000 shares, an increase of 16.8% from the August 30th total of 2,860,000 shares. Based on an average trading volume of 694,100 shares, the short-interest ratio is presently 4.8 days. Currently, 7.7% of the shares of the stock are short sold. View Core Laboratories' Current Options Chain.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Oceaneering International (OII), SemGroup (SEMG), Helix Energy Solutions Group (HLX), Hurricane Energy (HRCXF), Franks International (FI), RPC (RES), Liberty Oilfield Services (LBRT), Propetro (PUMP), Select Energy Services (WTTR), C&J Energy Services (CJ), National Energy Services Reunited (NESR), Keane Group (FRAC), North American Construction Group (NOA) and KLX Energy Services (KLXE).
What other stocks do shareholders of Core Laboratories own?
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
- Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
- Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
- Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
- Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Manning & Napier Group LLC (1.80%), Stephens Investment Management Group LLC (1.06%), Douglas Lane & Associates LLC (0.38%), Scout Investments Inc. (0.17%), Envestnet Asset Management Inc. (0.11%) and Gofen & Glossberg LLC IL (0.06%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.
Which institutional investors are selling Core Laboratories stock?
Which institutional investors are buying Core Laboratories stock?
CLB stock was purchased by a variety of institutional investors in the last quarter, including Stephens Investment Management Group LLC, Manning & Napier Group LLC, Douglas Lane & Associates LLC, Envestnet Asset Management Inc., State of Alaska Department of Revenue, Stephens Inc. AR and First Bank & Trust. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett and Jan Willem Sodderland. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $40.39.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $1.79 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.
What is Core Laboratories' official website?
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (NYSE CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
